Display options
Cite
Streja E, Streja D. Does the Benefit of Cholesterol-Lowering of a Given Magnitude Depend on the Drug Intervention Used?. Circ Cardiovasc Qual Outcomes. 2019;12(8):e005599doi: 10.1161/CIRCOUTCOMES.119.005599.
Streja, E., & Streja, D. (2019). Does the Benefit of Cholesterol-Lowering of a Given Magnitude Depend on the Drug Intervention Used?. Circulation. Cardiovascular quality and outcomes, 12(8), e005599. https://doi.org/10.1161/CIRCOUTCOMES.119.005599
Streja, Elani, and Streja, Dan. "Does the Benefit of Cholesterol-Lowering of a Given Magnitude Depend on the Drug Intervention Used?." Circulation. Cardiovascular quality and outcomes vol. 12,8 (2019): e005599. doi: https://doi.org/10.1161/CIRCOUTCOMES.119.005599
Streja E, Streja D. Does the Benefit of Cholesterol-Lowering of a Given Magnitude Depend on the Drug Intervention Used?. Circ Cardiovasc Qual Outcomes. 2019 Aug;12(8):e005599. doi: 10.1161/CIRCOUTCOMES.119.005599. Epub 2019 Aug 15. PMID: 31412735.
Copy Download .nbib Format: NLM
Share it on

Circ Cardiovasc Qual Outcomes. 2019 Aug;12(8):e005599. doi: 10.1161/CIRCOUTCOMES.119.005599. Epub 2019 Aug 15.

Does the Benefit of Cholesterol-Lowering of a Given Magnitude Depend on the Drug Intervention Used?.

Circulation. Cardiovascular quality and outcomes

Elani Streja, Dan Streja

Affiliations

  1. Division of Nephrology and Hypertension, Department of Medicine, Harold Simmons Center for Kidney Disease Research and Epidemiology, University of California Irvine Medical Center, Orange, CA (E.S.).
  2. Nephrology Section, Tibor Rubin Veterans Affairs Medical Center, Long Beach, CA (E.S.).
  3. Division of Endocrinology, Diabetes and Metabolism, David Geffen School of Medicine at UCLA, Greater Los Angeles VA Healthcare System, West Los Angeles VA Medical Center (D.S.).

PMID: 31412735 DOI: 10.1161/CIRCOUTCOMES.119.005599

[No abstract available.]

Keywords: Editorials; cholesterol; epidemiological studies; ezetimibe; proprotein convertase

Substances

MeSH terms

Publication Types